Focus on safety in treating patients with ACOS

Patients with clinical features of both asthma and COPD should be generally be treated with both inhaled corticosteroids and bronchodilators even though there is sparse evidence to guide optimal therapy and continuing debate about the validity of the ‘asthma-COPD overlap syndrome’ (ACOS), according to a recent review. The review, in Lancet Respiratory Medicine, was co-authored ...

Already a member?

Login to keep reading.

© 2021 the limbic